Cell and gene therapy and ATMP manufacturing moves fast—from personalized, small-batch production to rapid facility expansion. Maintaining GMP compliance in this environment requires monitoring systems that scale with your process. Manufacturers of cell and gene therapies and ATMPs face unique challenges: ensuring traceability, rapid turnaround, and zero tolerance for downtime while production models shift from scale-up to scale-out.
This webinar covers monitoring requirements specific to cell and gene therapy and ATMP operations, including multi-site data integrity, cryogenic storage, and rapid system validation. Learn how scalable monitoring solutions can reduce risk, speed implementation, and future-proof your operations against evolving regulatory and technological demands.
Learning Agenda
- Challenges in Small-Batch & Personalized Production
- Maintaining GMP Compliance During Scale-Up/Scale-Out
- Ensuring Multi-Site Data Integrity & Traceability
- Cryogenic Storage & Rapid Validation Best Practices
- Designing Scalable Monitoring Systems
- Risk Mitigation in Cell and Gene Therapy & ATMP Manufacturing
- Navigating Regulatory Trends & Technology Innovations
Who Should Attend
- Cell and Gene Therapy & ATMP Manufacturers
- Biotech & Pharmaceutical Professionals
- Regulatory Affairs Experts
- Operations & Quality Managers
- IT & Automation Engineers
If you have already attended or registered for this webinar, please click here. Otherwise, please watch the recorded webinar by filling the form.